TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of Participants Who developed glucose metabolic disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the concentration-time curve (AUC) from Time 0 extrapolated to infinity (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of occurrence of maximum concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coronary microvascular dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HAT measured with DUS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hearing aid use hours
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of Erythema Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change of Photoaging Skin Condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change of Subjective Pain Evaluation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of Skin Capacitance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change of Skin Conditions of patients assessed by Janus Facial Analysis System
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of radiotherapy-related genitourinary adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Immediate Change in Pleasant Sensation Ratios
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Longer-Term Change in Pleasant Sensation Ratios
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of patients progressing to further investigations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Attribution Questionnaire (AQ-27)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mental Help Seeking Intention Scale (MHSIS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Correct identification of the cricothyroid membrane within a minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pain Reaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Percentage of Positive PCa Screens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Degree of cellulite
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Levels of sensory alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Peripheral muscle oxygen measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Perceived Stress Levels
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in Emotional State
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Physiological Stress Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of at least one postoperative complication
Endpoint domain: Adverse events/effects
Primary endpoint: 3D spatial resolved Deuterium metabolite imaging (DMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 3D spatial resolved SLOW-EPSI MRSI metabolite mapping
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Addiction Stigma Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: FEF (Forced Expiratory Flow)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: urethrocutaneous fistula
Endpoint domain: Adverse events/effects
Primary endpoint: hematoma
Endpoint domain: Adverse events/effects
Primary endpoint: neomeatus retraction
Endpoint domain: Adverse events/effects
Primary endpoint: Peak breath alcohol concentration (mg%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motivation for alcohol
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Area under the concentration versus time curve of XZP-3621 and its metabolite in plasma (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum serum concentration (Cmax) of XZP-3621 and its metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathological features of tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: DNA-Fragmentation index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of CSF diversion
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of epithelial eosinophilia to < 15 eos/hpf
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quadriceps muscle Electromyography voltage level change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with effective HSCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak decrease in overnight respiratory exchange ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: change in respiratory exchange ratio during high-dose insulin infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean score on Indian Family Violence and Control Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: AUDIT (Alcohol Use Disorders Identification Test) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Capture of incidentally identified lung nodules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Performance comparison of EMR-based algorithm to establish risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of LiquidLung plasma-based gene expression assay for biomarker subset selection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cervical Sagittal Alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Patient Satisfaction with patient's Nose (FACE-Q)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Patient Satisfaction with patient's Nose (Rhinoplasty Outcome Evaluation scale)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Size of artifact-degraded regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self- or parent-reported respiratory symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Lung function measured by spirometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hours of inotropic support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Distress level change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Gray matter volume change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Gray matter thickness change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in state emotion regulation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Initial overall response to Orelabrutinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained overall response to Orelabrutinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BDNF Expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BDNF Serum Concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall postoperative morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: Progression to persistent dysglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Progression to stage 3 type 1 diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of Participants with Major Congenital Malformation
Endpoint domain: Adverse events/effects
Primary endpoint: Change in LDL oxidability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Accuracy of snakebite incidence data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of fathers-to-be accepting prenatal consultation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Global and segmentary longitudinal 2D-speckle tracking value of the left ventricle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline stress perception at follow-up
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline depression at follow-up
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline anxiety at follow-up
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline cognitive function at follow-up
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline immune function at follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change according to the scale of the DN4 Neuropathic Pain Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change according to the scale of the PainDetect questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in relative power in slow frequencies (alpha and theta ranges) on the EEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Patient and care partner experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cmax: Maximum Observed Plasma Concentration for TAK-994
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUClast: Area Under the Plasma Concentration-time Curve From Time 0 to the Time of the Last Quantifiable Concentration for TAK-994
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC∞: Area Under the Plasma Concentration-time Curve from Time 0 to Infinity for TAK-994
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-Operative Uncorrected Distance Visual Acuity (UDVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Single surgery anatomic success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IBD-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Evaluation of Respiratory Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: accuracy on an attention demanding cognitive test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Heart-failure related hospitalisations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Composite MACE
Endpoint domain: Mortality/survival
Primary endpoint: Vaccine effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall changes in sitting time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Quality of Life Measured by Neck Disability Index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Glasgow Outcome Scale-Extended (GOSE 2-Way)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cumulative Fluid balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade ≥3 TRAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Fine Motor Skill Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hand Reaction Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Handgrip Strength Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intubation-related hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: locoregional recurrence free survival
Endpoint domain: Mortality/survival
Primary endpoint: Bone mineral density by DXA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Test Adoption Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: accuracy of hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mathematics performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: seroreversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary hCG concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: HPT-related hormone measurements in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Biotin measurements in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Progression to ARDS within 7 days
Endpoint domain: Mortality/survival
Primary endpoint: Change in general self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of red cell concentrate transfused
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: improvement in Vaginal Health Index (VHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in Vulvovaginal atrophy (VVA) symptoms using the Visual analog scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of quality of sexual function using the validated Portuguese version of the Female Sexual Function Index (FSFI)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 60-min glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Patient attitude on chronic pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in Diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in Hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients recruited in each cohort
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of faeces samples collected in each cohort
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of plasma samples collected in each cohort
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of biopsy samples collected in each cohort
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Emotional functioning
Endpoint domain: Life impact
Primary endpoint: Nicotine Withdrawal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSAX view score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: apical view score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Technical success of stent placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: patient engagement
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in Pain Intensity Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Addiction Severity Index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spinal mobilization force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spinal mobilization rate of force application
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin moisturization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: DBS kit assay performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent IOP change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional connections between cerebral hemispheric regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Soft-tissue pathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal neovascularization as a proportion of the total corneal area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change in Columbia Suicide Severity Rating Scale (C-SSRS) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Tolerability for tVNS
Endpoint domain: Adverse events/effects
Primary endpoint: Change in lymphocyte count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Diagnostic performance of new biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Insulin Regulated Amino Peptidase sérique (IRAPs) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inflammation markers levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lipidome markers levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the severity of insomnia
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Acute radiation dermatitis severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: students' knowledge of sun prevention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of Dose Limit Toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of dose discontinuation and dose reduction due to ADRs
Endpoint domain: Adverse events/effects
Primary endpoint: Change in autonomic dysfunction symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in postural heart rate increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postoperative time to the first passage of flatus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in breast/chest wall volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Eating disorder pathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alterations of brain network connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of sleep disorders before CABG
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Sleep quality before CABG
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Solicited local adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Solicited systemic AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Change in daily ratings of behavioral difficulties
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intravasation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of PJI
Endpoint domain: Adverse events/effects
Primary endpoint: Serum levels of troponin-T
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum levels of D-dimer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment Coverage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Ilaprazole AUCt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of attended writing sessions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Amount of time spent writing
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total urinary excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Pathological complete remission (pCR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Regeneration of dental pulp
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breastfeeding Identification and Assessment Scale (LATCH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (AUC0-96h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: unplanned requirement for postoperative invasive or noninvasive ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Solicited injection-site Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Solicited daily body temperature with fever
Endpoint domain: Adverse events/effects
Primary endpoint: Solicited systemic Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Anaphylaxis/hypersensitivity AEs of special interest (AESI)
Endpoint domain: Adverse events/effects